Home › Stargardt Disease › Michigan
Stargardt Disease clinical trials in Michigan
5 studies for Stargardt Disease are looking for participants at sites in Michigan.
Cities in Michigan
Study of ALK-001 on the Progression of Stargardt Disease
- Foundation for Vision Research, Grand Rapids
RecruitingPhase 3
Ages 8 to 45 · All sexes · Updated Sep 18, 2026 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Michigan Health - Kellogg Eye Center, Ann Arbor
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- University of Michigan Kellogg Eye Center, Ann Arbor
RecruitingObservational study
Ages 5 and older · All sexes · Updated Mar 11, 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- University of Michigan Kellogg Eye Center, Ann Arbor
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Dec 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Kellogg Clinical Research Center, Ann Arbor
RecruitingObservational study
Ages 12 to 65 · All sexes · Updated Sep 19, 2025 · NCT06435000From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.